Bambusa Therapeutics
About:
Bambusa Therapeutics operates as biotechnology company.
Top Investors: INCE Capital, Biotechnology Value Fund, Salvia GmbH, Dawn Biopharma
Description:
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies.
Total Funding Amount:
$15M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
Founders:
Helmut Jeggle, Shanshan Xu
Number of Employees:
Last Funding Date:
2024-09-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai